|
|
Volumn 17, Issue 3, 2000, Pages 573-578
|
|
Peripheral blood tumor cell load reflects the clinical activity of the disease in patients with carcinoma of the breast.
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS;
DOXORUBICIN;
DRUG DERIVATIVE;
NAVELBINE;
VINBLASTINE;
ARTICLE;
BLOOD;
BREAST TUMOR;
CANCER STAGING;
CARCINOMA;
CELL COUNT;
DISEASE COURSE;
FEMALE;
FLOW CYTOMETRY;
FOLLOW UP;
HOSPITALIZATION;
HUMAN;
IMMUNOMAGNETIC SEPARATION;
LEUKAPHERESIS;
METASTASIS;
MULTIMODALITY CANCER THERAPY;
PATHOLOGY;
POSTOPERATIVE PERIOD;
SENSITIVITY AND SPECIFICITY;
TUMOR EMBOLISM;
TUMOR RECURRENCE;
ANTINEOPLASTIC AGENTS;
ANTINEOPLASTIC AGENTS, HORMONAL;
BREAST NEOPLASMS;
CARCINOMA;
CELL COUNT;
COMBINED MODALITY THERAPY;
DISEASE PROGRESSION;
DOXORUBICIN;
FEMALE;
FLOW CYTOMETRY;
FOLLOW-UP STUDIES;
HUMANS;
IMMUNOMAGNETIC SEPARATION;
LEUKAPHERESIS;
NEOPLASM CIRCULATING CELLS;
NEOPLASM METASTASIS;
NEOPLASM RECURRENCE, LOCAL;
NEOPLASM STAGING;
POSTOPERATIVE PERIOD;
SENSITIVITY AND SPECIFICITY;
SEVERITY OF ILLNESS INDEX;
VINBLASTINE;
MLCS;
MLOWN;
|
|
EID: 0034268349
PISSN: 10196439
EISSN: None
Source Type: Journal
DOI: 10.3892/ijo.17.3.573 Document Type: Article |
|
Times cited : (63)
|
|
References (0)
|
